The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Editorial

Mitral valve-in-ring: the good, the bad, and the ugly

EuroIntervention 2016;11:1192-1194. DOI: 10.4244/EIJV11I10A221

Department of Cardiothoracic Surgery, Guy’s and St. Thomas’ Hospital, London, United Kingdom


The success of transcatheter aortic valve implantation (TAVI) has had a huge impact on the management of patients with aortic stenosis1. At the heart of it is a basic idea of implanting a heart valve which does not need sutures and is held securely by tissue because of relative oversizing. Some of the issues associated with the first two transcatheter heart valve (THV) devices, i.e., SAPIEN (Edwards Lifesciences, Irvine, CA, USA), and CoreValve® (Medtronic, Minneapolis, MN, USA) were the inability to reposition, paravalvular leaks and conduction disturbances1. Second- and third-generation THV designs were introduced to address some of ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Percutaneous paravalvular leak closure? Perhaps a glimmer of hope after a long course of marginal success